Lv4
420 积分 2023-03-16 加入
Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications
2个月前
已完结
Phase 1 Study of [ 177 Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results
2个月前
已完结
FAP+ fibroblasts orchestrate tumor microenvironment remodeling in renal cell carcinoma with tumor thrombus
2个月前
已完结
177Lu-LNC1004 Radioligand Therapy in Patients with End-Stage Metastatic Cancers: A Single-Center, Single-Arm, Phase II Study
2个月前
已完结
The molecular blueprint of targeted radionuclide therapy
2个月前
已完结
Initial clinical experience with 90Y-FAPI-46 radioligand therapy for advanced stage solid tumors: a case series of nine patients
2个月前
已完结
Preclinical Evaluation of68Ga/177Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy
2个月前
已完结
Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation
2个月前
已完结
Optimizing FAP Radiopharmaceuticals: Key Insights from a Dose Escalation Study
2个月前
已关闭
Efficacy and Safety of [177Lu]Lu-DOTAGA.Glu.(FAPi)2 Therapy in Patients with Sarcoma
2个月前
已完结
皖公网安备34019202002308
